VWF and von Willebrand disease (hereditary or acquired): WIL-31 demonstrated the efficacy of prophylaxis with wilate, a plasma-derived VWF/FVIII concentrate containing VWF and FVIII in a 1:1 activity ratio, in adults and children (>6 years) with VWD of all types.